Ledo Nora, Ko Yi-An, Park Ae-Seo Deok, Kang Hyun-Mi, Han Sang-Youb, Choi Peter, Susztak Katalin
Renal Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Renal Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
J Am Soc Nephrol. 2015 Mar;26(3):692-714. doi: 10.1681/ASN.2014010028. Epub 2014 Sep 17.
Genome-wide association studies (GWASs) have identified multiple loci associated with the risk of CKD. Almost all risk variants are localized to the noncoding region of the genome; therefore, the role of these variants in CKD development is largely unknown. We hypothesized that polymorphisms alter transcription factor binding, thereby influencing the expression of nearby genes. Here, we examined the regulation of transcripts in the vicinity of CKD-associated polymorphisms in control and diseased human kidney samples and used systems biology approaches to identify potentially causal genes for prioritization. We interrogated the expression and regulation of 226 transcripts in the vicinity of 44 single nucleotide polymorphisms using RNA sequencing and gene expression arrays from 95 microdissected control and diseased tubule samples and 51 glomerular samples. Gene expression analysis from 41 tubule samples served for external validation. 92 transcripts in the tubule compartment and 34 transcripts in glomeruli showed statistically significant correlation with eGFR. Many novel genes, including ACSM2A/2B, FAM47E, and PLXDC1, were identified. We observed that the expression of multiple genes in the vicinity of any single CKD risk allele correlated with renal function, potentially indicating that genetic variants influence multiple transcripts. Network analysis of GFR-correlating transcripts highlighted two major clusters; a positive correlation with epithelial and vascular functions and an inverse correlation with inflammatory gene cluster. In summary, our functional genomics analysis highlighted novel genes and critical pathways associated with kidney function for future analysis.
全基因组关联研究(GWAS)已确定了多个与慢性肾脏病(CKD)风险相关的基因座。几乎所有的风险变异都位于基因组的非编码区域;因此,这些变异在CKD发生发展中的作用很大程度上尚不清楚。我们推测多态性会改变转录因子的结合,从而影响附近基因的表达。在此,我们研究了对照和患病人类肾脏样本中与CKD相关多态性附近转录本的调控情况,并使用系统生物学方法来确定潜在的因果基因以便进行优先排序。我们使用来自95个显微切割的对照和患病肾小管样本以及51个肾小球样本的RNA测序和基因表达阵列,对44个单核苷酸多态性附近的226个转录本的表达和调控进行了研究。来自41个肾小管样本的基因表达分析用于外部验证。肾小管区室中的92个转录本和肾小球中的34个转录本与估算肾小球滤过率(eGFR)显示出统计学上的显著相关性。鉴定出了许多新基因,包括ACSM2A/2B、FAM47E和PLXDC1。我们观察到任何单个CKD风险等位基因附近的多个基因的表达与肾功能相关,这可能表明基因变异会影响多个转录本。对与GFR相关的转录本进行网络分析突出了两个主要簇;一个与上皮和血管功能呈正相关,另一个与炎症基因簇呈负相关。总之,我们的功能基因组学分析突出了与肾功能相关的新基因和关键途径,以供未来分析。